-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Exhibition Report] Pharmaceutical wastewater is sewage wastewater containing antibiotics, antibiotics, and antiserum produced in the pharmaceutical production process.
The need for the healthy development of China's pharmaceutical industry
.
In recent years, China's pharmaceutical industry has developed rapidly and continues to grow.
According to statistics, the number of pharmaceutical enterprises in China increased by 549 from 2015 to 2020.
By 2020, the number of pharmaceutical manufacturing enterprises in China reached 7,665, a year-on-year increase of 3.
8%
.
In the context of the continuous growth of the number of pharmaceutical companies, the wastewater problem generated by the industry has also received more and more attention and attention from the state and enterprises
.
At the beginning of the "14th Five-Year Plan", pharmaceutical wastewater will become a key national problem.
Harmonious coexistence between man and nature”, to improve the quality and stability of the ecosystem; to continuously improve the quality of the environment; to accelerate the green transformation of the development mode
.
Among them, in the promotion of green development and continuous improvement of environmental quality, strengthening the treatment of pharmaceutical wastewater is the top priority, and it is one of the key issues that the country and the pharmaceutical industry need to overcome
.
The composition of wastewater in the pharmaceutical industry is complex, and if it is disposed of indiscriminately, it will seriously affect ecological security.
Taking antibiotic wastewater as an example, a media report in May 2019 stated: "The antibiotic content in most rivers in the world exceeds the standard, threatening the lives of tens of millions of people in 30 years
.
"In China, from the perspective of wastewater discharge from the pharmaceutical industry in the past few years, the problem of pharmaceutical wastewater is also worrying.
For example, according to the "2015 Environmental Statistics Annual Report" data, China's industrial wastewater discharge in 2015 was 19.
95 billion tons, of which the pharmaceutical industry wastewater.
The discharge amounted to 532.
587 million tons, accounting for about 2.
67% of the national industrial wastewater
.
The output value of the pharmaceutical industry accounts for only 1.
7% of the national total industrial output value, but the discharge of pharmaceutical sewage accounts for 2% of the national sewage discharge.
The problem should not be underestimated
.
The pharmaceutical industry wastewater not only contains a large amount of heavy metals and harmful chemicals, but also contains non-degradable pollutants, plus various acids, alkalis, tannins and anthraquinones.
If the treatment is not up to standard, it will bring a lot of negative effects to the environment.
It will also restrict the sustainable development of the pharmaceutical industry
.
2021 is the first year of China's "14th Five-Year Plan", and it is also the beginning of a new journey.
The country has listed the issue of wastewater transformation as an important content
.
According to the main goals of economic and social development during the "14th Five-Year Plan" period, China will deeply fight the tough battle of pollution prevention and control, establish and improve the environmental governance system, promote precise, scientific, legal and systematic pollution control, coordinately promote pollution reduction and carbon reduction, and continuously improve air, Water environment quality; to carry out in-depth pollution prevention and control actions, it is required to adhere to source prevention and control, comprehensive policies, and strengthen multi-pollutant coordinated control and regional coordinated governance
.
According to the “14th Five-Year Plan” pharmaceutical industry development path, it clarifies the improvement of the green development level of the API industry, solves the prominent problems restricting the development of the industry such as hazardous waste treatment and VOCS emission, and requires the improvement of the green manufacturing level of APIs and the development of clean production technology.
The application will be further promoted; the production of raw materials will be concentrated in advantageous enterprises, and a number of high-level green development parks of raw materials will be formed
.
In recent years, China has attached great importance to the problem of pharmaceutical wastewater, and has issued many policies to restrict it
.
For example, in addition to the relevant instructions of the "14th Five-Year Plan", as early as August 2008, China began to implement the "Pharmaceutical Industry Water Pollutant Discharge Standard".
The "Standard" includes 6 categories.
Under the implementation of the "Standard", The sewage discharge standards of pharmaceutical companies are increasing day by day
.
In addition, the "Twelfth Five-Year Plan for National Environmental Protection" pointed out that COD and ammonia nitrogen, the main substances in the pollutants of the pharmaceutical industry, must be included in the binding indicators; the outline of the "Twelfth Five-Year Plan for the Pharmaceutical Industry" also proposed new energy saving and emission reduction.
It is required that by the end of the "Twelfth Five-Year Plan", the energy consumption per unit of added value and the water consumption per unit of added value of the pharmaceutical industry will drop by more than 10% compared with the end of the "Eleventh Five-Year Plan", and the intensity of sewage discharge will be significantly reduced
.
With the advancement of a series of policies, during the 13th Five-Year Plan period, China's pollution prevention and control efforts have been intensified, the goal of reducing the total discharge of major pollutants has been exceeded, the efficiency of resource utilization has been significantly improved, and the ecological environment has been significantly improved
.
Policies are frequently increased, and new breakthroughs in pharmaceutical wastewater treatment technology have been continuously achieved.
Strengthening pharmaceutical wastewater treatment to meet the requirements of the "Comprehensive Wastewater Discharge Standard", thereby reducing the environmental pollution of pharmaceutical wastewater and the waste of water resources, is the realization of environmental protection and The dual goal of business efficiency
.
How to treat pharmaceutical wastewater up to standard and even reuse it to achieve near zero discharge has become the responsibility and obligation of contemporary enterprises
.
In recent years, China's policies on pharmaceutical wastewater treatment have frequently increased, which has also forced relevant wastewater treatment technologies to continuously achieve breakthroughs and progress
.
The difficulty of pharmaceutical wastewater treatment is that pharmaceutical wastewater has unstable water quality components, complex components, high concentration of toxic and harmful pollutants, high chroma, poor biodegradability and high content of refractory substances, and the stability of water quality and water quantity is not stable.
High, high salinity is present, with some COD
.
To get to the bottom of it, the problem can be solved
.
According to the relevant characteristics of pharmaceutical wastewater, high-pressure nanofiltration membrane element and high-pressure reverse osmosis membrane element system came into being
.
Among them, the high-pressure nanofiltration membrane element in the system can realize the separation of COD and salt, and the concentration of salt, and the water produced can be reused in the previous process
.
Another pharmaceutical wastewater reuse and near-zero discharge process uses Wastout microwave multi-effect technology and extreme separation technology to carry out advanced treatment of pharmaceutical wastewater, thereby solving the problems of high cost of pharmaceutical wastewater treatment and refractory organic matter degradation, and realizes water purification.
Recycling of resources
.
In addition, new technologies such as MVR (Mechanical Vapor Recompression) and membrane treatment have become increasingly prominent in the field of pharmaceutical wastewater treatment in recent years, especially in the treatment of high-concentration organic wastewater, which has attracted the attention of pharmaceutical companies
.
Statistics show that in 2020, the number of pharmaceutical manufacturing enterprises in China has reached 7,665, a year-on-year increase of 3.
8%
.
In addition, data predicts that in 2022, the total annual compound growth rate of China's pharmaceutical manufacturing industry revenue will be about 8.
52%, and the total sales revenue will reach 4,603.
4 billion yuan
.
With the increase in the number of pharmaceutical companies and the rapid development of the industry, the total discharge of pharmaceutical wastewater may become larger, the composition will become more and more complex, and there will be more and more new types of pollutants.
Therefore, the treatment methods also need to be increasingly diversified.
.
At this stage, the commonly used treatment methods for pharmaceutical industry wastewater include physicochemical, biological, and biochemical methods
.
However, there are certain limitations in the treatment of pharmaceutical wastewater by a single treatment technology.
In order to better realize the treatment of pharmaceutical wastewater, explore the combination of physicochemical methods, advanced oxidation technology and biological treatment, so that it can play a synergistic role and become a high-content pharmaceutical wastewater.
development direction of the research field
.
Under the high pressure of environmental protection, the country is paying more and more attention to the problems of industrial sewage and wastewater, and the demand for sewage treatment will increase.
Data shows that the output value of the sewage treatment industry in 2020 will be about 84 billion yuan, and it will reach 130 billion yuan by 2025.
The resulting wastewater treatment equipment industry exhibition space will be very broad
.
As the pharmaceutical industry is a large producer of wastewater, the development prospects of the related pharmaceutical wastewater treatment equipment industry are even greater
.
Attracted by the huge market, many equipment companies have deployed
.
With the continuous rise of domestic and foreign manufacturers of sewage treatment and membrane treatment equipment for wastewater treatment in the pharmaceutical industry, this will inevitably bring new technologies or solutions to the industry and further promote the green development of the pharmaceutical industry
.
So when the pharmaceutical wastewater treatment equipment industry is developing rapidly, how should the sewage treatment and membrane treatment exhibitors who are in it meet the opportunities and challenges? On June 2-4, 2021, the 14th Shanghai International Water Exhibition will be held at the Shanghai National Convention and Exhibition Center (Hongqiao).
As the annual feast of the water industry, it will provide a good exchange for the pharmaceutical wastewater treatment industry.
platform
.
At that time, more than 1,600 exhibitors, including Ruishenghua, American Hyde Power, DuPont, Suez, Keli, Qiaofa, Wardtop, Willstar, Times Wharton, Visaibo, etc.
, will compete on the same stage, or will Bringing a new "wind vane" to the development of the industry
.
The need for the healthy development of China's pharmaceutical industry
.
In recent years, China's pharmaceutical industry has developed rapidly and continues to grow.
According to statistics, the number of pharmaceutical enterprises in China increased by 549 from 2015 to 2020.
By 2020, the number of pharmaceutical manufacturing enterprises in China reached 7,665, a year-on-year increase of 3.
8%
.
In the context of the continuous growth of the number of pharmaceutical companies, the wastewater problem generated by the industry has also received more and more attention and attention from the state and enterprises
.
At the beginning of the "14th Five-Year Plan", pharmaceutical wastewater will become a key national problem.
Harmonious coexistence between man and nature”, to improve the quality and stability of the ecosystem; to continuously improve the quality of the environment; to accelerate the green transformation of the development mode
.
Among them, in the promotion of green development and continuous improvement of environmental quality, strengthening the treatment of pharmaceutical wastewater is the top priority, and it is one of the key issues that the country and the pharmaceutical industry need to overcome
.
The composition of wastewater in the pharmaceutical industry is complex, and if it is disposed of indiscriminately, it will seriously affect ecological security.
Taking antibiotic wastewater as an example, a media report in May 2019 stated: "The antibiotic content in most rivers in the world exceeds the standard, threatening the lives of tens of millions of people in 30 years
.
"In China, from the perspective of wastewater discharge from the pharmaceutical industry in the past few years, the problem of pharmaceutical wastewater is also worrying.
For example, according to the "2015 Environmental Statistics Annual Report" data, China's industrial wastewater discharge in 2015 was 19.
95 billion tons, of which the pharmaceutical industry wastewater.
The discharge amounted to 532.
587 million tons, accounting for about 2.
67% of the national industrial wastewater
.
The output value of the pharmaceutical industry accounts for only 1.
7% of the national total industrial output value, but the discharge of pharmaceutical sewage accounts for 2% of the national sewage discharge.
The problem should not be underestimated
.
The pharmaceutical industry wastewater not only contains a large amount of heavy metals and harmful chemicals, but also contains non-degradable pollutants, plus various acids, alkalis, tannins and anthraquinones.
If the treatment is not up to standard, it will bring a lot of negative effects to the environment.
It will also restrict the sustainable development of the pharmaceutical industry
.
2021 is the first year of China's "14th Five-Year Plan", and it is also the beginning of a new journey.
The country has listed the issue of wastewater transformation as an important content
.
According to the main goals of economic and social development during the "14th Five-Year Plan" period, China will deeply fight the tough battle of pollution prevention and control, establish and improve the environmental governance system, promote precise, scientific, legal and systematic pollution control, coordinately promote pollution reduction and carbon reduction, and continuously improve air, Water environment quality; to carry out in-depth pollution prevention and control actions, it is required to adhere to source prevention and control, comprehensive policies, and strengthen multi-pollutant coordinated control and regional coordinated governance
.
According to the “14th Five-Year Plan” pharmaceutical industry development path, it clarifies the improvement of the green development level of the API industry, solves the prominent problems restricting the development of the industry such as hazardous waste treatment and VOCS emission, and requires the improvement of the green manufacturing level of APIs and the development of clean production technology.
The application will be further promoted; the production of raw materials will be concentrated in advantageous enterprises, and a number of high-level green development parks of raw materials will be formed
.
In recent years, China has attached great importance to the problem of pharmaceutical wastewater, and has issued many policies to restrict it
.
For example, in addition to the relevant instructions of the "14th Five-Year Plan", as early as August 2008, China began to implement the "Pharmaceutical Industry Water Pollutant Discharge Standard".
The "Standard" includes 6 categories.
Under the implementation of the "Standard", The sewage discharge standards of pharmaceutical companies are increasing day by day
.
In addition, the "Twelfth Five-Year Plan for National Environmental Protection" pointed out that COD and ammonia nitrogen, the main substances in the pollutants of the pharmaceutical industry, must be included in the binding indicators; the outline of the "Twelfth Five-Year Plan for the Pharmaceutical Industry" also proposed new energy saving and emission reduction.
It is required that by the end of the "Twelfth Five-Year Plan", the energy consumption per unit of added value and the water consumption per unit of added value of the pharmaceutical industry will drop by more than 10% compared with the end of the "Eleventh Five-Year Plan", and the intensity of sewage discharge will be significantly reduced
.
With the advancement of a series of policies, during the 13th Five-Year Plan period, China's pollution prevention and control efforts have been intensified, the goal of reducing the total discharge of major pollutants has been exceeded, the efficiency of resource utilization has been significantly improved, and the ecological environment has been significantly improved
.
Policies are frequently increased, and new breakthroughs in pharmaceutical wastewater treatment technology have been continuously achieved.
Strengthening pharmaceutical wastewater treatment to meet the requirements of the "Comprehensive Wastewater Discharge Standard", thereby reducing the environmental pollution of pharmaceutical wastewater and the waste of water resources, is the realization of environmental protection and The dual goal of business efficiency
.
How to treat pharmaceutical wastewater up to standard and even reuse it to achieve near zero discharge has become the responsibility and obligation of contemporary enterprises
.
In recent years, China's policies on pharmaceutical wastewater treatment have frequently increased, which has also forced relevant wastewater treatment technologies to continuously achieve breakthroughs and progress
.
The difficulty of pharmaceutical wastewater treatment is that pharmaceutical wastewater has unstable water quality components, complex components, high concentration of toxic and harmful pollutants, high chroma, poor biodegradability and high content of refractory substances, and the stability of water quality and water quantity is not stable.
High, high salinity is present, with some COD
.
To get to the bottom of it, the problem can be solved
.
According to the relevant characteristics of pharmaceutical wastewater, high-pressure nanofiltration membrane element and high-pressure reverse osmosis membrane element system came into being
.
Among them, the high-pressure nanofiltration membrane element in the system can realize the separation of COD and salt, and the concentration of salt, and the water produced can be reused in the previous process
.
Another pharmaceutical wastewater reuse and near-zero discharge process uses Wastout microwave multi-effect technology and extreme separation technology to carry out advanced treatment of pharmaceutical wastewater, thereby solving the problems of high cost of pharmaceutical wastewater treatment and refractory organic matter degradation, and realizes water purification.
Recycling of resources
.
In addition, new technologies such as MVR (Mechanical Vapor Recompression) and membrane treatment have become increasingly prominent in the field of pharmaceutical wastewater treatment in recent years, especially in the treatment of high-concentration organic wastewater, which has attracted the attention of pharmaceutical companies
.
Statistics show that in 2020, the number of pharmaceutical manufacturing enterprises in China has reached 7,665, a year-on-year increase of 3.
8%
.
In addition, data predicts that in 2022, the total annual compound growth rate of China's pharmaceutical manufacturing industry revenue will be about 8.
52%, and the total sales revenue will reach 4,603.
4 billion yuan
.
With the increase in the number of pharmaceutical companies and the rapid development of the industry, the total discharge of pharmaceutical wastewater may become larger, the composition will become more and more complex, and there will be more and more new types of pollutants.
Therefore, the treatment methods also need to be increasingly diversified.
.
At this stage, the commonly used treatment methods for pharmaceutical industry wastewater include physicochemical, biological, and biochemical methods
.
However, there are certain limitations in the treatment of pharmaceutical wastewater by a single treatment technology.
In order to better realize the treatment of pharmaceutical wastewater, explore the combination of physicochemical methods, advanced oxidation technology and biological treatment, so that it can play a synergistic role and become a high-content pharmaceutical wastewater.
development direction of the research field
.
Under the high pressure of environmental protection, the country is paying more and more attention to the problems of industrial sewage and wastewater, and the demand for sewage treatment will increase.
Data shows that the output value of the sewage treatment industry in 2020 will be about 84 billion yuan, and it will reach 130 billion yuan by 2025.
The resulting wastewater treatment equipment industry exhibition space will be very broad
.
As the pharmaceutical industry is a large producer of wastewater, the development prospects of the related pharmaceutical wastewater treatment equipment industry are even greater
.
Attracted by the huge market, many equipment companies have deployed
.
With the continuous rise of domestic and foreign manufacturers of sewage treatment and membrane treatment equipment for wastewater treatment in the pharmaceutical industry, this will inevitably bring new technologies or solutions to the industry and further promote the green development of the pharmaceutical industry
.
So when the pharmaceutical wastewater treatment equipment industry is developing rapidly, how should the sewage treatment and membrane treatment exhibitors who are in it meet the opportunities and challenges? On June 2-4, 2021, the 14th Shanghai International Water Exhibition will be held at the Shanghai National Convention and Exhibition Center (Hongqiao).
As the annual feast of the water industry, it will provide a good exchange for the pharmaceutical wastewater treatment industry.
platform
.
At that time, more than 1,600 exhibitors, including Ruishenghua, American Hyde Power, DuPont, Suez, Keli, Qiaofa, Wardtop, Willstar, Times Wharton, Visaibo, etc.
, will compete on the same stage, or will Bringing a new "wind vane" to the development of the industry
.
